en · de · es · fr · pt
cjc-1295-notes.peptides7501.com › Blog › Cjc-1295 Structure And Mechanism — Worked Examples

Cjc-1295 Structure And Mechanism — Worked Examples

By Editorial Desk · published 2025-07-10 · last reviewed 2025-07-31 · Blog

If you have been reading about reversed-phase HPLC and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Last reviewed on 2025-07-31. Where a claim depends on a specific study, the study is described rather than over-claimed.

CJC-1295 Structure And Mechanism

CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.

The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.

Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.

Compound Identity and Development History

The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.

Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.

CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.

Cjc-1295 at a glance

PropertyValueNotes
Physical formLyophilized white powderSupplied as a freeze-dried solid for research use
Molecular weightApproximately 3,647 Da (DAC form)Lower for the variant lacking the albumin-binding moiety
SolubilitySoluble in water and aqueous bufferTypically dissolved in sterile or bacteriostatic water
Typical storage temperature−20 °C or belowDry powder, desiccated and protected from light
Common analytical methodReversed-phase HPLC with mass spectrometryUsed for purity estimation and identity confirmation

Background and Molecular Design

The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.

CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.

Related pages on this site

Analytical Characterization and Storage

Stability depends heavily on physical state. A lyophilized powder kept dry, desiccated, and shielded from light typically holds its integrity for months to years at minus twenty degrees Celsius, and longer at minus eighty. Once dissolved, the peptide becomes far more vulnerable, since peptide bond hydrolysis, oxidation of susceptible residues, and aggregation all proceed faster in solution. Buffers near neutral pH are generally gentler than strongly acidic or alkaline conditions. Repeated freeze-thaw cycles and exposure to air-liquid interfaces during vigorous mixing cause losses that are easy to overlook.

Verification matters because research peptides vary widely in quality. A certificate of analysis is only as reliable as the method behind it, and a single chromatographic trace reveals little about counter-ions, residual solvents, or water content. Independent laboratories commonly pair mass confirmation with chromatographic purity and, where relevant, quantify water along with acetate or trifluoroacetate content. Reported purity figures are not standardized across suppliers, so a stated value such as ninety-eight percent is not directly comparable unless the analytical method, column, and detection wavelength accompany it.

Further detail

The varied geography and climatology of Italy has led to many cases of spontaneous mummification. Italian mummies display the same diversity, with a conglomeration of natural and intentional mummification spread across many centuries and cultures. The oldest natural mummy in Europe was discovered in 1991 in the Ötztal Alps on the Austrian-Italian border. Nicknamed Ötzi, the mummy is a 5,300-year-old male believed to be a member of the Tamins-Carasso-Isera cultural group of South Tyrol. Despite his age, a recent DNA study conducted by Walther Parson of Innsbruck Medical University revealed Ötzi has 19 living genetic relatives. The Capuchin Catacombs of Palermo were built in the 16th century by the friars of Palermo's Capuchin monastery. Originally intended to hold the deliberately mummified remains of dead friars, interment in the catacombs became a status symbol for the local population in the following centuries. Burials continued until the 1920s, with one of the final burials being that of Rosalia Lombardo. In all, the catacombs host nearly 8000 mummies. The most recent discovery of mummies in Italy came in 2010, when sixty mummified human remains were found in the crypt of the Conversion of St Paul church in Roccapelago di Pievepelago, Italy. Built in the 15th century as a cannon hold and later converted in the 16th century, the crypt had been sealed once it had reached capacity, leaving the bodies to be protected and preserved. The crypt was reopened during restoration work on the church, revealing the diverse array of mummies inside.

=== Neonatal Diabetes Mellitus === Postnatal proinsulin is crucial for metabolic regulation. However, proinsulin in neonates is important for normal development of the nerves of the eye, development of the heart, and general survival of embryonic cells. Regulation of the concentration of proinsulin during embryonic development is crucial, as too much or too little of the peptide can cause defects and death of the fetus. Thus far in the study of neonatal diabetes mellitus, only amino acid change mutations found in the B domain lead to the disease.

=== Rumors and jokes === Rumors surrounding the initial use of lefse are the claims by Norwegian Americans that it was made by and used to sustain the Vikings, but potatoes were not introduced into Norway until long after the Vikings' time. Although many Scandinavian-Americans do enjoy and eat the foods of their ethnic traditions, there is no shortage of tall-tales and jokes surrounding certain food, as well. Lefse was not excluded from these rumors. Among other things, lefse has been said to be "so tasteless that many mistakenly eat the paper doily under the stack and do not know the difference."

== Transportation == Minnesota Highway 23 serves as a main route in Cold Spring and Interstate 94, the major highway of the region, is nearby, linking Minneapolis, St. Paul, Fargo, Chicago, and Milwaukee. Cold Spring is also served by County Roads 2 and 50, providing north–south access in and out of the city. Cold Spring's proximity to St. Cloud allows for convenient access to St. Cloud Regional Airport, as well as the city's Amtrak and Greyhound stations.

Sources: en.wikipedia.org

Background from the literature

Clinton. In October 2002 at the International Symposium on Chromatography in London, Klaus Mosbach was presented the Martin Gold Medal, at the Royal Society, for the year 2000, by the Executive Committee of the Chromatographic Society. It was awarded him "in recognition of his major contributions to the field of separation science over many years". Previous recipients of this award are inter alia F. Regnier (1993), C. Horvath (1994) and W.H. Pirkle (1990). Mosbach published more than 537 peer reviewed scientific articles and reviews with an H-Index of 77. Mosbach wrote and edited four volumes of methods in enzymology series on Immobilized Enzymes, by Academic press (44,132,133,134). In addition he has received and applied for 84 patents.

=== Reception by Appalachians === Many Appalachians appreciated the memoir's recounting of Vance's childhood experiences but protested the book's generalizations of those experiences to Appalachian culture. Some Appalachian critics argued that Vance caricatured Appalachia and relied on existing stereotypes. They blamed the book's popularity for amplifying these stereotypes. Further complaints included that Vance blamed poverty on individuals and their decisions rather than documented systemic and historic issues. Vance's critiques of Appalachian culture included calling many people in the community lazy, and the books' subtitle, "A Memoir of a Family and Culture in Crisis", offended some Appalachian critics with its implied condemnation of Appalachian culture. Other complaints said the book flattened Appalachian culture and erased its diversity. At the 2018 Appalachian Studies Association conference, Young Appalachian Leaders and Learners (Y'ALL) protested Vance during a panel by turning their chairs from him and singing "Which Side are You On?".

=== Mantle === A hyphal sheath known as the mantle, which often has more biomass than the Hartig net interface, envelops the root. The structure of the mantle is variable, ranging from a loose network of hyphae to a structured and stratified arrangement of tissue. Often, these layers resemble plant parenchyma tissue and are referred to as pseudoparenchymatous. Because the root is enveloped by the mantle it is often affected developmentally. EcM fungal partners characteristically suppress root hair development of their plant symbiont. They can also increase root branching by inducing cytokinins in the plant. These branching patterns can become so extensive that a single consolidated mantle can envelop many root tips at a time. Structures like this are called tuberculate or coralloid ectomycorrhizas. The mantles of different EcM pairs often display characteristic traits such as color, extent of branching, and degree of complexity which are used to help identify the fungus, often in tandem with molecular analyses. Fruiting bodies are also useful but are not always available.

Half-Life: Blue Shift is an expansion pack for the first-person shooter video game Half-Life (1998). It was developed by Gearbox Software and published by Sierra On-Line. Blue Shift was the second expansion for Half-Life, originally intended as part of a Dreamcast port of Half-Life. Although the Dreamcast port was cancelled, the Windows version was released as a standalone product on June 12, 2001. As with Gearbox's previous expansion pack, Opposing Force (1999), Blue Shift returns to the setting and events of Half-Life, but portrays the story through the eyes of another character. Players control security guard Barney Calhoun, employed by the Black Mesa Research Facility, who must fight his way to safety during an alien invasion. Blue Shift also includes a graphics pack that upgrades the Half-Life models and textures. Blue Shift received mixed reviews. Many reviewers were critical of the short length and lack of new content, although the new graphics were praised.

Amane Waseda reported δD of oil samples in northeast Japan to increase from around −130‰ to around −110‰ with higher maturity. At low thermal maturity, dos Santos Neto and Hayes reported δD of saturate fraction of oil in Portiguar Basin derived from a lacustrine environment is -90‰, and from a marine-evaporitic environment is -120‰ to −135‰. Bulk analysis of oil, which yields a complex mixture of organic compounds, obscures much of the valuable information. Switching to compound-specific study greatly expanded our understanding of hydrogen isotopes of oil. Analyzing HIC at the compound level avoids problems from differences in exchange rates, simplifies sources and products relationships, and draws a much more detailed picture. δDs of n-alkanes are generally thought to be representative of oil as they are the major components. Schimmelmann et al. confirmed that alkane fractions have almost the same DHRs as whole oils. Depending on source material type and maturity, δD of n-alkanes can vary from −100‰ to −180‰. A common phenomenon of various oil and matured rock derived n-alkanes is a trend of increasing δD with chain length. For example, Li et al. analyzed oils from the Western Canada Sedimentary Basin and found δD increased between 20‰ and 40‰ from C13 to C27. This "isotope slope" is an artifact of kinetic fractionation associated with thermal cracking of carbon chains. This trend has been experimentally reproduced and theoretically modeled by Tang et al. N-alkanes are also known to preserve detailed information of source material. Li et al.

Sources: en.wikipedia.org

Frequently asked questions

How does CJC-1295 differ from modified GRF(1-29)?

The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.

Is CJC-1295 an approved medicine?

It has not been approved by major regulatory agencies for any therapeutic indication. Material sold under this name is typically distributed for laboratory research only. Clinical use is not supported by large controlled trials.

What is known about its half-life?

Early human studies of the albumin-binding form reported circulation half-lives on the order of several days. The value depends on assay method and study design. Estimates for the form without the binding moiety are considerably shorter.

What is CJC-1295?

It is a synthetic peptide analogue of growth hormone-releasing hormone. Four substitutions in its sequence make it more resistant to enzymatic degradation than the natural hormone. In the version carrying a drug affinity complex, the peptide binds albumin and remains in circulation for days.

Network